Lucem Health Engages Amendola to Lead Comprehensive PR Strategy Emphasizing Thought Leadership

Initiative to raise awareness of Lucem’s AI-powered disease detection via strategic media relations, social media, and targeted content 

SCOTTSDALE, Ariz., Oct. 9, 2025 /PRNewswire/ — Amendola, a nationally recognized, award-winning healthcare technology and life sciences public relations and marketing firm, announced Lucem Health has selected Amendola to execute an integrated PR and marketing program to position the company as a leader in AI-powered early disease detection.

Lucem Health, which was started by Mayo Clinic and is based in Raleigh, N.C., offers a portfolio of AI-driven solutions for identifying undiagnosed patients with certain chronic diseases before symptoms emerge using only their EHR records. It has solutions specifically for arrhythmias, colorectal cancer, liver disease, and type 1 diabetes. Amendola is providing a comprehensive PR and marketing program to showcase these revolutionary screenings, which can be done automatically without patient involvement or disruption of providers’ workflows.

“Too often, providers are forced to react to disease after it has progressed,” said Sean Cassidy, CEO and Co–Founder of Lucem Health. “By helping caregivers proactively identify patients with undiagnosed disease, we enable earlier engagement, more effective interventions, and better outcomes. We partnered with Amendola to help bring this story to market.”

Agency president Jodi Amendola said: “Leveraging AI to identify people at greater risk of serious disease by using clinically trained algorithms to detect patterns in their medical records is surely one of the marvels of modern healthcare technology. We’re excited to help raise awareness of Lucem Health’s solutions through PR, social media, and marketing programs.”

About Lucem Health

Lucem Health helps healthcare providers accelerate disease detection and treatment using practical, responsible AI—so they can improve patients’ lives and increase the clinical and financial yield from today’s scarce care delivery resources. Learn more at www.lucemhealth.com 

About Amendola


Amendola
, part of Supreme Group, is an award-winning, insights-driven public relations and marketing firm that integrates media relations, social media, content, and lead gen programs to move healthcare, life sciences/pharma and healthcare IT decision-makers to action. The agency represents some of the industry’s best-known brands as well as groundbreaking startups disrupting the status quo. Nearly 90% of its client base represents multi-year clients and/or repeat client executives. Amendola’s seasoned team of PR and marketing pros understand the ongoing complexities of the healthcare ecosystem and provide strategic guidance and creative direction to drive positive ROI, boost reputation and increase market share. Making an impact since 2003, Amendola combines traditional and digital media to fuel meaningful and measurable growth. For more information about the industry’s “A-Team,” visit this website and follow us on LinkedIn

Media Contact: Marcia G. Rhodes / mrhodes@acmarketingpr.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/lucem-health-engages-amendola-to-lead-comprehensive-pr-strategy-emphasizing-thought-leadership-302579031.html

SOURCE Amendola, part of Supreme Group

Staff

Recent Posts

TempraMed Launches National Brick and Mortar Pharmacy Roll Out, Shipping Products to Maccabi Pharmacies Across Israel

Key Commercialization Milestone in Retail Pharmacy Network that Serves Over 2.8 Million Insured MembersVancouver, British…

2 hours ago

NuGen Medical Devices Inc. Provides Update on Health Canada License

Toronto, Ontario--(Newsfile Corp. - February 5, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"…

11 hours ago

Field Medical Presents Late Breaking Field PULSE Trial Data at AF Symposium 2026

Demonstrating Instantaneous Ablation Through High-Voltage Waveforms and Efficient Point-by-Point Pulsed Field AblationCARDIFF-BY-THE-SEA, Calif., Feb. 5,…

11 hours ago

LEADOPTIK Announces First-in-Human Use of FDA-Cleared LIA™ System

SAN JOSE, Calif., Feb. 5, 2026 /PRNewswire/ -- LEADOPTIK, Inc., a medical technology company focused…

11 hours ago

Dräger PSS® AirBoss SCBA Now Available for Purchase in North America

Now Available for Purchase, AirBoss Delivers an NFPA 1970:2025 SCBA Built for the Way American…

17 hours ago

Greenway Health® Named Most Improved Physician Practice Solution 2026 by KLAS Research

KLAS recognition highlights Greenway's momentum in modernizing physician practice technologyTAMPA, Fla., Feb. 5, 2026 /PRNewswire/…

17 hours ago